bpc 157 stable form BPC-157 Peptide: Mechanisms, Benefits, and Scientific Applications BPC-157 – Research Peptide |

Phase I human trial of parent molecule (TB-4) showed no serious adverse events Mild injection site reactions possible Same theoretical angiogenesis/tumor concern as BPC-157 Head rush or lightheadedness reported anecdotally at higher doses Can You Stack BPC-157 and TB-500

Safety : Insufficient needle length or incorrect gauge can lead to complications like medication leakage or tissue irritation

If I have any of this wrong, feel free to correct me (addressing more experienced members of this forum) The problem with a retest at this point is that after 6 injections, the B12 level will likely be elevated and it will be very difficult to know what the original value would have been

[DOI] [PubMed] [Google Scholar] 26.Filli L, Schwab ME

The major efficacy outcome measure was overall survival and additional efficacy outcome measures were time to disease progression, overall response rate, and response duration